Immuneering officer buys 2,626 IMRX shares
Immuneering Corp's Chief People Officer, Leah R. Neufeld, reported buying 2,626 shares of the company's Class A common stock on January 13, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Immuneering Corp's Chief People Officer, Leah R. Neufeld, reported buying 2,626 shares of the company's Class A common stock on January 13, 2026. The purchase was recorded at a price of $4.153 per share and is classified as a direct acquisition. After this transaction, Neufeld directly holds 25,970 Class A common shares of Immuneering Corp.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Class A Common Stock | 2,626 | $4.153 | $11K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Immuneering (IMRX) report for Leah R. Neufeld?
Immuneering Corp reported that Leah R. Neufeld, its Chief People Officer, purchased 2,626 shares of Class A common stock on January 13, 2026.
What is Leah R. Neufeld’s role at Immuneering (IMRX)?
Leah R. Neufeld is an officer of Immuneering Corp, serving as the company’s Chief People Officer.
Was the Immuneering (IMRX) insider transaction a purchase or a sale?
The Form 4 shows a transaction code “P”, indicating a purchase of Class A common stock by Leah R. Neufeld.
AI-generated analysis. How Rhea-AI works. Not financial advice.